Team
Partners
Science
Pipeline
Platforms
Engine
Resources
News & Events
Investors
Contact
Careers
Cell Reports
LY-CoV1404 (bebtelovimab) potently neutralizes SARS–CoV–2 variants
Post navigation
Previous:
Cell Reports
Next:
Immunity